The botanical ancestor of aspirin, with strong RCT evidence for low back pain and moderate evidence for osteoarthritis. Gentler on the stomach than NSAIDs, minimal antiplatelet effect — but carries the same hard contraindications as aspirin.
Traditions: European herbalism, Egyptian medicine, Greek medicine, Indigenous North American
Multiple traditions agree on use.
Ebers Papyrus records willow bark for pain and inflammation — one of the oldest written records of plant medicine.
Hippocrates documented chewing willow bark for fever, pain, and inflammation. Dioscorides and Pliny the Elder later described it for fever, gout, and articular complaints.
Used consistently across Germany, England, and France for fever, rheumatic pain, and headache. Rev. Edmund Stone's 1763 letter to the Royal Society of London formalized clinical observation, directly triggering the chain of events that led to salicin isolation (1829) and aspirin (1899). German Commission E, ESCOP, and EMA/HMPC have all codified traditional indications.
Native Salix species (S. nigra, S. lucida, others) used by multiple tribal traditions for fever, headache, toothache, and rheumatic pain — parallel development of the same therapeutic insight as Europe.
White willow has the most specific evidence base of any anti-inflammatory herb: two landmark RCTs, one active-comparator trial against a COX-2 inhibitor, and a 6-month observational study. Evidence is strongest for low back pain (strong), moderate for osteoarthritis (mixed RCTs), and insufficient for rheumatoid arthritis. Fever and headache indications rest on traditional evidence and pharmacopoeial recognition rather than RCTs.
39% pain-free at 4 weeks with 240 mg salicin vs 6% placebo (p<0.001); dose-dependent: 21% at 120 mg. n=210. Improvements appeared within week 1 at high dose.
Willow bark equivalent to rofecoxib (COX-2 inhibitor) with no statistically significant difference in outcomes. Willow bark approximately 40% less expensive. n=228.
45.6% pain improvement maintained from week 3 through 6 months, 0 significant adverse events. n=436, mixed OA/back pain population.
6 RCTs, n=329: pain SMD −0.31 (95% CI −0.53 to −0.08; p=0.007) vs placebo; physical function WOMAC SMD −0.80. Adverse event risk not significantly different from comparators (OR 1.37; p=0.26).
Only preparation with RCT support. Split morning and evening. Look for products specifying salicin content in mg, not just extract weight. Assalix (Steigerwald) is the extract used in the main RCTs.
Taste: Bitter, astringent, woody. Classic bark flavor. Tolerable if you like strong herbal teas.
1–2 teaspoons bark per 240ml cold water; bring to boil, simmer 10–15 minutes, strain. Boiling required — steeping does not adequately extract phenolic glycosides. Salicin content varies by species, bark source, and processing; cannot guarantee dose equivalence to RCT protocols.
1:5 ratio, 25–40% ethanol. Traditional pharmacy preparation; not the form used in clinical trials. Ethanol extracts in research are different from artisan tinctures. Salicin delivery is variable.
White willow bark is the botanical that directly produced aspirin. Not metaphorically — salicin was isolated from willow bark in 1829, salicylic acid synthesized from it in 1838, and aspirin commercialized by 1899. The plant preceded the pharmaceutical by at least 3,500 years.
But white willow isn’t aspirin. At the standard clinical dose (240 mg salicin/day), the resulting serum salicylate is equivalent to only ~87 mg acetylsalicylic acid — far below aspirin’s analgesic threshold (325–650 mg) [8]. The clinical effect comes from a combination of salicylates, polyphenols, and flavonoids that inhibit TNF-α and NF-kB pathways aspirin doesn’t touch [8]. This also explains the better GI profile and minimal antiplatelet effect.
Strong evidence (multiple RCTs):
Moderate evidence:
Insufficient evidence:
Few plants have a more direct line to modern pharmacology.
~1550 BCE: The Ebers Papyrus (Egypt) records willow bark for pain and inflammation — among the oldest documented medicinal plant uses on record.
~400 BCE: Hippocrates documents chewing willow bark for fever, pain, and inflammation. The practice spreads through Rome — Dioscorides and Pliny the Elder record it for fever, gout, and articular complaints. It moves through medieval Europe as a routine remedy for fever, rheumatics, and headache across German, English, and French herbalist traditions.
1763: The decisive moment. Reverend Edmund Stone writes to the Royal Society of London with his formalized observations that willow bark reliably reduces fever. His letter triggered the scientific investigations that would follow.
1829–1899: Henri Leroux isolates salicin. Raffaele Piria synthesizes salicylic acid from it. Charles Gerhardt makes the acetylated precursor. Felix Hoffmann at Bayer stabilizes it. Aspirin launches commercially in 1899.
In parallel, Indigenous North American traditions independently arrived at the same plant family — native Salix species (S. nigra, S. lucida, and others) — for fever, headache, toothache, and rheumatic pain. The traditions were separate; the pharmacological insight was identical.
Today, German Commission E, ESCOP, and EMA/HMPC all formally recognize willow bark for fever, rheumatic complaints, headache, and back pain — reflecting ≥30 years of documented European medicinal use required for “traditional use” status [10].
Standardized extract (evidence-based, most practical):
The only preparation used in RCTs. Choose products that state salicin content in mg.
| Dose | Effect at 4 Weeks (Low Back Pain) |
|---|---|
| 240 mg salicin/day | 39% pain-free vs 6% placebo [1] |
| 120 mg salicin/day | 21% pain-free vs 6% placebo [1] |
To hit 240 mg salicin at 15% standardization: approximately 1,600 mg extract daily. Split between morning and evening with food.
Traditional decoction:
Boiling is required — a simple steep doesn’t extract phenolic glycosides from bark adequately. Salicin content in raw bark varies by species, harvest time, and processing. You’re working in the right range, but cannot match the precision of standardized extract.
Tincture (traditional pharmacy, not RCT-validated):
For pain management matching the clinical evidence: standardized extract at 240 mg salicin/day. For traditional use or preference for whole-plant preparations: decoction per WHO guidelines, with the understanding that dose is approximate.
Take with food. For low back pain, look for early signal at week 1–2 [1]; evaluate fully at week 4. For osteoarthritis, expect 4–6 weeks minimum before assessing. Long-term use up to 6 months has observational safety data behind it [3].
Baseline (1 week before starting):
During trial (weeks 1–4):
Track the same markers. Compare:
RED FLAGS — Stop immediately:
What you might notice: fewer days reaching for pain medication, gradual pain reduction over 2–4 weeks, better physical function by week 6.
White willow bark decoction tastes like what it is: tree bark. Bitter, astringent, drying. The tannins leave a woody pucker in the mouth — think concentrated black tea, all structure and no sweetness.
It’s not unpleasant if you like strong, bitter herbal teas. It’s not pleasant if you don’t. Encapsulated standardized extract sidesteps all of this completely and is what the clinical trials used anyway. If taste matters to your adherence, capsules are the right call.
The central problem: Unlike OTC aspirin, willow bark supplements in the US are unregulated as drugs. Products often list only extract weight — “1000 mg willow bark extract” — with no salicin content specified. You cannot calculate your dose from extract weight alone, and you are not reproducing the clinical protocol.
The USP (2019) identified that US supplement market willow bark products commonly lack the safety warnings that aspirin carries by law — Reye syndrome warnings, pregnancy contraindications, aspirin-allergy flags — despite generating meaningful salicylic acid levels [7].
What to look for:
Avoid: Products specifying only “proprietary blend” or extract weight without salicin mg. You cannot calculate dose equivalence to the evidence base.
White willow bark works because it produces the same class of compounds that became aspirin — plus polyphenols and flavonoids that add anti-inflammatory action through pathways aspirin doesn’t reach. At standard doses, it’s gentler on the stomach and has minimal blood-thinning effect. The evidence for low back pain is genuinely strong: 39% pain-free at 4 weeks vs 6% placebo in a 210-person RCT [1], equivalent to a COX-2 inhibitor at lower cost [2].
The safety picture is honest and non-negotiable: the hard contraindications (aspirin allergy, children, pregnancy, nursing) are identical to aspirin. “Natural” doesn’t create an exception — salicylic acid is salicylic acid regardless of source. If you’re allergic to aspirin, this is not a botanical alternative. If a child has fever, this is not a safer aspirin substitute.
For the right person — adult with chronic back pain or OA, no salicylate allergy, seeking NSAID-level relief with better GI tolerance — the data is straightforward. Use standardized extract at 240 mg salicin/day. Check that the salicin content is actually listed on the label. Give it four weeks.
Duration: Minimum 4 weeks. Osteoarthritis may need 6 weeks before full effect. Long-term use up to 6 months appears safe in observational data.
What to notice:
Take with food. Effects for low back pain may begin within the first week — the high-dose group in the main RCT showed improvements by week 1 [1]. Unlike aspirin, you won't notice blood-thinning effects at standard doses — that's a feature. Individual variation exists: some get clear relief, others don't respond. Four weeks is the minimum evaluation period.
Generally considered: caution
Contraindications:
Pregnancy/Nursing: Contraindicated in both pregnancy and breastfeeding. Same precautions as aspirin apply: salicylates cross the placenta, risk of ductus arteriosus complications, and pass into breast milk with slow neonatal elimination.
At standard doses (240 mg salicin/day), adverse event rates are not significantly different from placebo or comparator analgesics in clinical trials (OR 1.37; p=0.26) [4]. Does NOT damage the gastric lining like aspirin or NSAIDs. Minimal antiplatelet effect at standard doses. Drug interactions: anticoagulants (warfarin, heparin — additive bleeding risk), other salicylate medications (cumulative load), NSAIDs (additive GI risk), methotrexate (theoretical reduced renal clearance). USP 2019 identified a regulatory gap: unlike OTC aspirin, US supplement market willow bark products often lack mandatory warnings for aspirin allergy, children, and pregnancy. Check your label.